Progyny Company

Progyny is the fertility benefits company in the US that combines service, science, technology and data to provide fertility solutions for self-insured employers. Progyny’s approach offers members a comprehensive value-based treatment plan that is based on the latest medical science and technology. The benefit plans are designed to improve outcomes, shorten time to pregnancy and reduce total fertility-related costs. The mission is to be the industry leader in comprehensive and inclusive fertility benefits that help people have a child and achieve the best possible outcomes. They accomplish this through their commitment to science and through personalized support that is fueled by hope and accomplished with care.

Total Funding: $115,549,451
Headquarters: New York, New York, United States
Funding Status: IPO
Employee Number: 101-250
Estimated Revenue: $10M to $50M
Investment Stage: N/A
Last Funding Type: Venture - Series Unknown
Number Of Exists: Venture - Series Unknown
Technology: Longevity FemTech
Investor Type: Company
Last Funding Date: 2017-11-01
Investors Number: 6
Founded Date: 01-01-2008
Industry: Reproductive Health & Contraception